Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis Keystone, E., Taylor, P., Genovese, M., Schlichting, D., de la Torre, I., Beattie, S., Rooney, T. J RHEUMATOL PUBL CO. 2015: 1292

View details for Web of Science ID 000357280700113